The size and purpose of the activist investor’s stake was not immediately clear, the person said.
Toms Capital, a New York-based activist investor, last year pushed for strategic changes at Tylenol producer Kenvue Inc. and built a stake in
In March, McCormick announced a ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
